Quidel ROA 2006-2019 | QDEL

Current and historical return on assets (ROA) values for Quidel (QDEL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Quidel ROA for the three months ending September 30, 2019 was 12.67%.
Quidel ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $0.07B $0.87B 8.64%
2019-06-30 $0.07B $0.85B 8.23%
2019-03-31 $0.07B $0.91B 7.95%
2018-12-31 $0.07B $0.81B 9.16%
2018-09-30 $0.04B $0.79B 4.41%
2018-06-30 $0.02B $0.76B 2.69%
2018-03-31 $0.01B $0.87B 1.68%
2017-12-31 $-0.01B $0.94B -1.67%
2017-09-30 $-0.01B $0.41B -1.50%
2017-06-30 $-0.00B $0.40B -0.26%
2017-03-31 $0.00B $0.40B 0.78%
2016-12-31 $-0.01B $0.39B -3.70%
2016-09-30 $-0.01B $0.38B -3.13%
2016-06-30 $-0.01B $0.37B -3.05%
2016-03-31 $-0.01B $0.38B -3.18%
2015-12-31 $-0.01B $0.41B -1.40%
2015-09-30 $0.00B $0.42B 0.23%
2015-06-30 $-0.00B $0.43B -1.00%
2015-03-31 $-0.00B $0.46B -0.56%
2014-12-31 $-0.01B $0.45B -2.57%
2014-09-30 $-0.01B $0.27B -5.24%
2014-06-30 $-0.01B $0.26B -4.50%
2014-03-31 $-0.01B $0.27B -2.61%
2013-12-31 $0.01B $0.27B 2.64%
2013-09-30 $0.02B $0.27B 5.83%
2013-06-30 $0.02B $0.27B 7.19%
2013-03-31 $0.02B $0.26B 7.02%
2012-12-31 $0.01B $0.24B 2.11%
2012-09-30 $-0.00B $0.24B -1.22%
2012-06-30 $-0.00B $0.23B -1.17%
2012-03-31 $-0.00B $0.24B -1.53%
2011-12-31 $0.01B $0.28B 2.62%
2011-09-30 $0.01B $0.27B 2.39%
2011-06-30 $0.00B $0.25B 0.42%
2011-03-31 $0.00B $0.26B 1.32%
2010-12-31 $-0.01B $0.22B -4.99%
2010-09-30 $0.01B $0.21B 4.32%
2010-06-30 $0.03B $0.22B 15.58%
2010-03-31 $0.03B $0.23B 19.76%
2009-12-31 $0.03B $0.17B 23.57%
2009-09-30 $0.02B $0.15B 14.15%
2009-06-30 $0.01B $0.12B 6.72%
2009-03-31 $0.01B $0.13B 5.09%
2008-12-31 $0.02B $0.14B 13.60%
2008-09-30 $0.02B $0.15B 15.27%
2008-06-30 $0.02B $0.13B 13.82%
2008-03-31 $0.02B $0.13B 13.55%
2007-12-31 $0.01B $0.13B 10.70%
2007-09-30 $0.02B $0.12B 19.21%
2007-06-30 $0.02B $0.11B 19.70%
2007-03-31 $0.02B $0.12B 18.22%
2006-12-31 $0.02B $0.13B 18.30%
2006-09-30 $0.01B $0.11B 11.66%
2006-06-30 $0.01B $0.11B 11.01%
2006-03-31 $0.01B $0.12B 13.40%
2005-12-31 $-0.01B $0.11B -8.74%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.954B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $151.583B 20.94
Abbott Laboratories (ABT) United States $151.168B 27.57
Stryker (SYK) United States $76.313B 25.66
Boston Scientific (BSX) United States $61.440B 29.00
Baxter (BAX) United States $42.463B 25.75
Essilor Luxottica (ESLOY) France $33.468B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.550B 19.17
Terumo (TRUMY) Japan $27.062B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.531B 0.00
Coloplast (CLPBY) Denmark $25.294B 39.03
ResMed (RMD) United States $21.653B 39.94
Smith & Nephew SNATS (SNN) United Kingdom $19.279B 0.00
Sunny Optical Technology (SNPTF) China $19.151B 0.00
Insulet (PODD) United States $11.373B 541.06
Bio-Rad Laboratories (BIO) United States $11.201B 53.76
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.203B 21.24
Perrigo (PRGO) Ireland $7.117B 13.27
Canopy Growth (CGC) Canada $6.501B 0.00
Haemonetics (HAE) United States $6.146B 41.53
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.890B 30.64
ICU Medical (ICUI) United States $3.830B 24.97
Neogen (NEOG) United States $3.545B 59.33
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.165B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.121B 0.00
Aurora Cannabis (ACB) Canada $2.648B 0.00
National Vision Holdings (EYE) United States $2.432B 54.89
Agios Pharmaceuticals (AGIO) United States $2.411B 0.00
Cardiovascular Systems (CSII) United States $1.577B 0.00
InMode (INMD) Israel $1.516B 0.00
AtriCure (ATRC) United States $1.226B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.162B 23.28
Phibro Animal Health (PAHC) United States $0.994B 18.61
NanoString Technologies (NSTG) United States $0.944B 0.00
Lantheus Holdings (LNTH) United States $0.802B 20.04
Eagle Pharmaceuticals (EGRX) United States $0.771B 29.55
TG Therapeutics (TGTX) United States $0.709B 0.00
Quanterix (QTRX) United States $0.705B 0.00
LeMaitre Vascular (LMAT) United States $0.698B 39.25
PetIQ (PETQ) United States $0.675B 16.46
Omeros (OMER) United States $0.655B 0.00
Cerus (CERS) United States $0.574B 0.00
Surmodics (SRDX) United States $0.570B 59.24
HEXO (HEXO) $0.537B 0.00
OraSure Technologies (OSUR) United States $0.492B 29.52
Owens & Minor (OMI) United States $0.474B 17.53
MacroGenics (MGNX) United States $0.474B 0.00
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.71
Meridian Bioscience (VIVO) United States $0.396B 13.62
BioLife Solutions (BLFS) United States $0.331B 134.92
Zynex (ZYXI) United States $0.329B 37.22
Bovie Medical (APYX) United States $0.275B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
United Health Products (UEEC) United States $0.249B 0.00
Viemed Healthcare (VMD) United States $0.242B 25.52
Vapotherm (VAPO) United States $0.227B 0.00
Repro-Med Systems (KRMD) United States $0.195B 0.00
Liberty Health Sciences (LHSIF) Canada $0.192B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
Chimerix (CMRX) United States $0.151B 0.00
Female Health (VERU) United States $0.148B 0.00
Rockwell Medical (RMTI) United States $0.141B 0.00
Cytosorbents (CTSO) United States $0.128B 0.00
Fonar (FONR) United States $0.128B 9.03
MTech Acquisition (KERN) United States $0.114B 0.00
United-Guardian (UG) United States $0.091B 23.15
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00